Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
FDA Discloses Responses, Toxicities For Burzynski’s “Antineoplastons”
This article is from
The Cancer Letter
archive.
Vol. 24 No. 16 | April 24, 1998
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
NCI Resources, Services Available For Cancer Research
June 7, 1996
TCL Archive
In the States: Arizona Approves Legislation on Patient Care Costs in Trials
May 5, 2000
TCL Archive
FDA News: FDA Lifts Clinical Hold On CTI’s Tosedostat
January 31, 2014
TCL Archive
NTP Board Oks Seven Compounds For Tests
April 22, 1983
TCL Archive
DCE Board Approves Concept For 14-19 New Grants, Four New Contracts
November 4, 1988
TCL Archive
Pre-Emptive Treatment Helped Curtail Panitumumab Toxicity
January 30, 2009